600,000 seniors have signed up for obesity drugs under new Medicare program

CMS Administrator Mehmet Oz said 600,000 seniors signed up for GLP-1 weight-loss medications in the first two months of a new federal access program. The uptake signals strong demand expansion for GLP-1 therapies, with implications for healthcare utilization and potential sales growth for providers/pharmas tied to these treatments.